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Introduction
● Metformin is an oral medication
used to treat Type II Diabetes
and is the first-line drug for
treatment.
● Metformin is the fourth most
prescribed medication in the
United States and has been
prescribed to over 78 million
patients since 20171.
● Metformin increases glucose
uptake of cells and decreases
hepatic glucose production,
leading to lower blood glucose
levels2.
● Metformin may help prevent
cancer, improve cardiovascular
health, and protect against
inflammation, therefore focus has
been directed on its potential to
be an anti-aging drug3.

Research Focus
The research was centered
primarily around examining the
following questions:

Results

Discussion

Table 1: Literature Survey of Metformin and Aging Studies

● The literature survey indicates
that metformin treatment extends
lifespan in C. elegans, Mus
musculus, and Bombyx mori
(male), though it has the opposite
effect in Drosophila (Table 1).

Model
Organism

Lifespan Extension
with Metformin
Treatment

Significant Healthspan Markers

Papers
Cited

C. elegans

Increased mean
lifespan

↑ youthful locomotor ability; ↓ levels of stored fat; ↑ Boxidation; Altered microbial folate and methionine
metabolism; Displayed a younger cuticle

4, 5, 6

No significant effect on
lifespan; Decreased
lifespan at higher
concentrations

↓ levels of triglycerides at 10 mM and 100 mM; At 25
mM, female flies laid more eggs than control at 7
days; At 50 mM, female flies laid more eggs than
control at 7 days, but fewer at 14 days.

7, 8

Bombyx mori

Increased lifespan in
male silkworms; No
significant effect on
lifespan of female
silkworms

↑ survival rate of silkworms subjected to feeding
stress by 13.46% but did not increase
thermotolerance; ↓ silk production; ↓ fecundity in
female silkworms

9

Mus musculus

Increased mean
lifespan

↑ B-oxidation of fatty acids; ↓ lipid synthesis; ↑ fitness
performance in male C57BL/6 strain; ↓ age-related
switch-off of estrous function; ↓ mean size and
accumulation of mammary adenocarcinomas in
female HER-2/Neu strain; ↓ the first tumor detection
by 22% and 25% when started at 3 and 9 months

10, 11,
12, 13,
14, 15,
16

Drosophila
melanogaster

Rattus
norvegicus

No significant effect on
↓ mean body weight compared to the control group
lifespan
during weeks 48-74; Food consumption was similar to
control group

Images were adopted from public sources and are available upon request.

Figure 1: The Effect of Metformin Treatment on Drosophila Lifespan
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have on aging and lifespan?
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● Survivorship curve of wild-type flies fed
diets with concentrations of 1-50 mM of
metformin.
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3. What metabolic side effects
(on stress response, body
weight, or feeding) does
metformin cause?
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2. Does metformin promote
health and longevity?
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● Lifespan extension was observed in flies
when supplemented with 1 mM of
metformin (p<0.05 by log-rank test).
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● Flies maintained on diets with
concentrations of metformin higher than
10 mM experienced lifespan reduction.
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Methods

● Analyzed preliminary data from
Drosophila melanogaster lifespan
and feeding assays.
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● Food consumption measured in wild-type
flies using the Con-Ex method.
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Optical Density

● Conducted a literature review
analyzing published primary
research articles about metformin
and its effects on lifespan and
healthspan in various model
organisms.

Figure 2: Metformin Increased Food Intake in Drosophila

● This graph represents absorbance
density vs. different metformin
concentrations administered in diet.
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● Higher concentrations of metformin
increased food intake in flies (p<0.05 by
t-test for 5mM and 10mM compared to
control).

● Additionally, metformin treatment
affects several metabolic
parameters, such as triglyceride
levels, in C. elegans, Drosophila,
and Mus musculus (Table 1).
● Our data shows that lifespan
extension was observed in
Drosophila treated with a low
dose of metformin. These results
demonstrate that metformin has
the potential to extend lifespan,
contrary to previous Drosophila
lifespan studies (Fig 1).
● Higher concentrations of
metformin in diet appear to
increase feeding behavior in
Drosophila, which may have a
negative impact on lifespan
extension (Fig 2).
● Future studies will involve
conducting experiments with
Drosophila to verify these
preliminary results and to identify
the molecular mechanisms that
mediate lifespan extension and
increase food intake by
metformin.
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